RAC2 and myeloid sarcoma: Although MR is a powerful tool for investigating the causal relationship between an exposure and an outcome, this approach cannot identify the specific molecular mechanism(s) of the relationship or confirm the hypothesis in this study regarding statins, RAC2, and MS risk.